MIRA INFORM REPORT

 

 

Report Date :           

09.05.2011

 

IDENTIFICATION DETAILS

 

Name :

LACORIUM HEALTH INTERNATIONAL PTY LTD

 

 

Formerly Known As :

Laderma Health International P/L

 

 

Registered Office :

Tower 2 14/101 Grafton Street, Bondi Junction, New South Wales 2022

 

 

Country :

Australia

 

 

Date of Incorporation :

07.11.2008

 

 

Legal Form :

Proprietary Company

 

 

Line of Business :

Research, Development, Manufacture and Marketing of skin care, natural wellbeing and organic products

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

Payment Behaviour :

Unknown

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – December 31, 2010

 

Country Name

Previous Rating

                   (30.09.2010)                  

Current Rating

(31.12.2010)

Australia

a1

a1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

NAME GIVEN     

 

LADERMA HEALTH INTERNATIONAL PTY LTD

 

 

SPECIAL NOTE        

 

On 6 May 2011 the subject changed name to Lacorium Health International P/L

 

 

REGISTERED NAME      

 

LACORIUM HEALTH INTERNATIONAL PTY LTD

ACN: 134 067 066

ABN: 36 134 067 066

 

     

CORPORATE SEARCH

 

Incorporation Date:                     07 Nov 2008

 

Incorporation State:                   New South Wales

 

Registered Office                       TOWER 2 14/101 GRAFTON Street

BONDI JUNCTION, New South Wales 2022 Australia

 

Number of Shares Issued:           100

 

Paid Capital:                              100

 

Shareholders                             STANTAIL TRADING PTY LIMITED

Number of Shares: 100

 

Directors                                   SHER, STEVEN DAVID

Appointment Date: 07 Nov 2008

Date of Birth: 22 Jan 1972

Gender: Male

Address: 3 MACLEAY Street NORTH BONDI, New South Wales 2026 Australia

Resident Overseas: No

 

Secretary                                  STEVEN DAVID SHER

Appointment Date: 07 Nov 2008

BUSINESS STRUCTURE

 

TRADING ADDRESS                 205 Victoria St

                                                BEACONSFIELD, VIC 2015

 

POSTAL ADDRESS                   Po Box 1422

                                     Bondi Junction NSW 1355

                       

TELEPHONE                             (612) 9693 6500

 

FACSIMILE                               (612) 9693 6575

 

HOLDING ENTITY                      STANTAIL TRADING P/L

 

ASSOCIATED ENTITIES            LADERMA P/L

                                                LADERMA INTERNATIONAL P/L

 

BANK                                       National Australia Bank

                                               

EMPLOYEES                            25        

 

 

BACKGROUND

 

The subject was incorporated in New South Wales on 7 November 2008 as Laderma Trading P/L changing name on 6 December 2010 to Laderma Health International P/L before adopting the current style on 6 May 2011.

 

 

OPERATIONS

 

The subject operates in the research, development, manufacture and marketing of skin care, natural wellbeing and organic products.

 

The group presently distributes its products to over 40 countries through pharmacies, healthfood stores and leading retailers.

 

Activities are conducted from premises located at the above listed trading address.

 

 

ADVERSE

                                               

A search of failed to trace any litigation listed against the subject at that date.

FINANCES

 

The subject is not required to lodge financial statements with the Australian Securities and Investments Commission.

 

During the current interview conducted with the subjects Financial Controller Vernon, he confirmed the subjects search and operational details, before requesting that any further queries pertaining to the subject must be conducted in writing. An email was subsequently sent to accounts@ladermahealth.com.au however a reply is yet to be received.

 

As a result, details pertaining to the subject’s financial and trading position were unable to be obtained for the current enquiry.

 

 

TRADE SURVEY

 

Details pertaining to the subjects suppliers were not provided for the current enquiry.

 

A trade survey on the subject was subsequently unable to be conducted.

 

 

SUMMARY

 

The subject was incorporated in New South Wales on 7 November 2008 under the current style.

 

During the current investigation, details pertaining to the subject’s financial and trading position were unable to be obtained for the current enquiry.

 

 

           


FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.44.78

UK Pound

1

Rs.73.43

Euro

1

Rs.65.27

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.